健康与医疗系统
How AI is reviving a century-old solution against antibiotic resistance
The spectre of a post-antibiotic era, where common infections could once again prove lethal, is rearing its head.
Ithri Benamara is CEO Associate at phagos, a biotech startup developing AI-powered phage therapy. He previously worked as a VC at EQT Ventures, one of Europe's leading investment firms, where he focused on identifying and backing transformative technology companies. Prior to EQT, Ithri also contributed to scaling carbon removal technologies with ClimeFi. He holds Master's degrees in Climate Change & Sustainable Finance from Ecole des Mines de Paris and EDHEC Business School.
最热内容